查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594616

肿瘤营养市场：按癌症、给药途径和最终用户分类 - 全球预测 2025-2030

Oncology Nutrition Market by Cancer (Breast, Head & Neck, Liver), Route of Administration (Oral, Parenteral), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肿瘤营养市场价值为30.6亿美元，预计到2024年将达到33.2亿美元，复合年增长率为8.61%，到2030年将达到54.6亿美元。

肿瘤营养报告包括客製化饮食策略，以支持癌症患者的治疗和康復，重点是改善营养状况、控制副作用和提高生活品质。这些营养需求源于癌症引起的代谢变化和治疗相关的副作用，因此量身定制的营养干预措施对于维持体重、肌肉质量和免疫功能至关重要。其应用范围从个人化饮食计划和补充到解决营养不良和恶病质。最终用途范围包括医院、专科诊所和居家照护机构，为患者提供全面的营养支援。该市场的关键成长要素包括全球癌症发病率增加、人们对营养在癌症治疗中重要性的认识不断提高以及营养诊断技术的进步。新的商机在于透过遗传和微生物组资料进行个人化营养治疗，这使得个人化计画能够显着改善治疗结果。利用这些机会的研究和开发工作包括投资与肿瘤学家和营养学家的研究合作，以製定精确的饮食指南，并与生物技术公司建立营养基因组解决方案的合作关係，其中包括：儘管存在成长潜力，但高治疗成本、报销问题以及癌症类型饮食需求差异等挑战可能会阻碍市场扩张。可以在植物来源营养食品、非侵入性营养评估工具和远端患者监护数位平台等领域进行创新，以优化治疗计划。深入研究针对癌症特定需求的机能性食品也是一个有前景的研究途径。肿瘤营养市场的本质是动态的，受到强调综合护理的不断发展的医疗范式的驱动。要在这个市场取得成功，需要随时了解临床研究、监管发展和消费者偏好，以保持竞争力，并在这个快速成长的细分市场中推动有意义的患者治疗结果。

主要市场统计
基准年[2023] 30.6亿美元
预测年份 [2024] 33.2亿美元
预测年份 [2030] 54.6亿美元
复合年增长率（%） 8.61%

市场动态：快速发展的肿瘤营养市场的关键市场洞察

供需的动态交互作用正在改变肿瘤营养市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 癌症患者增加
    • 癌症患者对营养支持的需求不断增长
    • 提高先进医疗设施的认知度和可近性
  • 市场限制因素
    • 癌症患者的优质营养产品高成本
  • 市场机会
    • 癌症患者营养补充品的进展
    • 为接受切除术的癌症患者提供增强免疫的营养补充剂
  • 市场问题
    • 製造复杂性

波特五力：驾驭肿瘤营养市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解肿瘤营养市场的外部影响

外部宏观环境因素在塑造肿瘤营养市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解肿瘤营养市场的竞争格局

对肿瘤营养市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：肿瘤营养市场供应商的绩效评估

FPNV定位矩阵是评估肿瘤营养市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划肿瘤营养市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，肿瘤营养市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症发生率上升
      • 肿瘤患者对营养支持的需求增加
      • 提高意识和使用先进医疗设施的机会
    • 抑制因素
      • 肿瘤学优质营养产品高成本
    • 机会
      • 肿瘤营养製剂的进展
      • 接受切除术的癌症患者的免疫增强组合
    • 任务
      • 与生产相关的复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章肿瘤营养市场：依癌症分类

  • 介绍
  • 胸部
  • 头部和颈部
  • 肝
  • 肺
  • 胰臟
  • 胃和消化系统

第七章肿瘤营养市场：依给药途径

  • 介绍
  • 口服
  • 胃肠外的

第八章肿瘤营养市场：依最终用户分类

  • 介绍
  • 居家医疗
  • 医院
  • 专科诊所

第九章北美及南美肿瘤营养市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太肿瘤营养市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的肿瘤营养市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • B. Braun SE
  • Baxter International, Inc.
  • BioSig Technologies, Inc.
  • Danone SA
  • FMC Corporation
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Healios Oncology Nutrition, LLC
  • Hormel Foods Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle SA
  • Nutra Healthcare Private Limited
  • OnCore Nutrition
Product Code: MRR-036C5CF3A8D2

The Oncology Nutrition Market was valued at USD 3.06 billion in 2023, expected to reach USD 3.32 billion in 2024, and is projected to grow at a CAGR of 8.61%, to USD 5.46 billion by 2030.

The scope of oncology nutrition encompasses dietary strategies tailored to support cancer patients throughout their treatment and recovery, focusing on improving nutritional status, managing side effects, and enhancing quality of life. The necessity of such nutrition arises from cancer-induced metabolic changes and treatment-related side effects, making tailored nutritional interventions essential for maintaining body weight, muscle mass, and immune function. Applications range from individualized meal planning and supplementation to addressing malnutrition and cachexia. End-use scope includes hospitals, specialty clinics, and home care settings providing comprehensive nutritional support to patients. Key growth factors in this market include increasing global cancer prevalence, heightened awareness of the importance of nutrition in cancer care, and technological advancements in nutritional diagnostics. Emerging opportunities lie in personalized nutrition based on genetic and microbiome data, which enables individualized plans that can significantly improve therapeutic outcomes. Recommendations for capitalizing on these opportunities include investing in research collaborations with oncologists and dietitians to develop precise dietary guidelines and fostering partnerships with biotechnology firms for nutritional genomics solutions. Despite the growth potential, challenges such as high treatment costs, reimbursement issues, and variability in dietary requirements across different cancer types may hinder market expansion. Innovations can be pursued in the areas of plant-based nutritional supplements, non-invasive nutritional assessment tools, and digital platforms for remote patient monitoring to optimize treatment plans. Delving into functional foods tailored for cancer-specific needs also presents a promising research avenue. The nature of the oncology nutrition market is dynamic, driven by evolving healthcare paradigms that emphasize integrative care. Success in this market necessitates staying abreast of clinical research, regulatory developments, and consumer preferences to remain competitive and drive meaningful patient outcomes in a burgeoning field.

KEY MARKET STATISTICS
Base Year [2023] USD 3.06 billion
Estimated Year [2024] USD 3.32 billion
Forecast Year [2030] USD 5.46 billion
CAGR (%) 8.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oncology Nutrition Market

The Oncology Nutrition Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cancer cases
    • Growing demand for nutritional feeding for oncology patients
    • Increased awareness and accessibility to advanced healthcare facilities
  • Market Restraints
    • High cost of premium nutrition products for oncology
  • Market Opportunities
    • Advancement of oncology nutritional feeding formulas
    • Immune-enhancing formulas for patients with cancer undergoing esophagectomy
  • Market Challenges
    • Complexities associated with the production

Porter's Five Forces: A Strategic Tool for Navigating the Oncology Nutrition Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oncology Nutrition Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oncology Nutrition Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oncology Nutrition Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oncology Nutrition Market

A detailed market share analysis in the Oncology Nutrition Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oncology Nutrition Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oncology Nutrition Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oncology Nutrition Market

A strategic analysis of the Oncology Nutrition Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oncology Nutrition Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Baxter International, Inc., BioSig Technologies, Inc., Danone S.A., FMC Corporation, Fresenius Kabi AG, Global Health Products, Inc., Healios Oncology Nutrition, LLC, Hormel Foods Corporation, Meiji Holdings Co., Ltd., Nestle S.A., Nutra Healthcare Private Limited, and OnCore Nutrition.

Market Segmentation & Coverage

This research report categorizes the Oncology Nutrition Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Cancer, market is studied across Breast, Head & Neck, Liver, Lung, Pancreatic, and Stomach & Gastrointestinal.
  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on End-user, market is studied across Home Care, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer cases
      • 5.1.1.2. Growing demand for nutritional feeding for oncology patients
      • 5.1.1.3. Increased awareness and accessibility to advanced healthcare facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of premium nutrition products for oncology
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement of oncology nutritional feeding formulas
      • 5.1.3.2. Immune-enhancing formulas for patients with cancer undergoing esophagectomy
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with the production
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oncology Nutrition Market, by Cancer

  • 6.1. Introduction
  • 6.2. Breast
  • 6.3. Head & Neck
  • 6.4. Liver
  • 6.5. Lung
  • 6.6. Pancreatic
  • 6.7. Stomach & Gastrointestinal

7. Oncology Nutrition Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Parenteral

8. Oncology Nutrition Market, by End-user

  • 8.1. Introduction
  • 8.2. Home Care
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Oncology Nutrition Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Oncology Nutrition Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Oncology Nutrition Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun SE
  • 3. Baxter International, Inc.
  • 4. BioSig Technologies, Inc.
  • 5. Danone S.A.
  • 6. FMC Corporation
  • 7. Fresenius Kabi AG
  • 8. Global Health Products, Inc.
  • 9. Healios Oncology Nutrition, LLC
  • 10. Hormel Foods Corporation
  • 11. Meiji Holdings Co., Ltd.
  • 12. Nestle S.A.
  • 13. Nutra Healthcare Private Limited
  • 14. OnCore Nutrition

LIST OF FIGURES

  • FIGURE 1. ONCOLOGY NUTRITION MARKET RESEARCH PROCESS
  • FIGURE 2. ONCOLOGY NUTRITION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ONCOLOGY NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ONCOLOGY NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ONCOLOGY NUTRITION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ONCOLOGY NUTRITION MARKET DYNAMICS
  • TABLE 7. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY BREAST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HEAD & NECK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PANCREATIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY STOMACH & GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ONCOLOGY NUTRITION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ONCOLOGY NUTRITION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ONCOLOGY NUTRITION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. ONCOLOGY NUTRITION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. ONCOLOGY NUTRITION MARKET, FPNV POSITIONING MATRIX, 2023